Abstract
Crohn’s disease and ulcerative colitis are inflammatory bowel diseases (IBD), which are thought to result from an inappropriate immunologic (autoimmune) response to luminal antibodies. Allogeneic stem cell transplantation (SCT) performed for coincidental diseases is able to cure both leukaemia and Crohn’s disease. Autologous SCT is currently performed worldwide for severe autoimmune diseases (SADs) because of its reduced transplant-related mortality (TRM). We report the case of a 30-year-old male patient with a 10-year history of severe Crohn’s disease, who developed Hodgkin’s disease and received an unmanipulated peripheral blood autologous transplant. Three years after the transplant the patient is in complete treatment-free remission of both diseases. Bone Marrow Transplantation (2000) 26, 921–923.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
McDonald SA, Palmen MJ, Van Rees EP, MacDonald TT . Characterization of the mucosal cell-mediated immune responce in IL-2 knockout mice before and after onset of colitis Immunology 1997 91: 73–80
Elliott DE, Murray JA, Weinstock JV Inflammatory bowel disease and celiac disease . In: Rose NR, Mackay IR (eds) The Autoimmune Disease Academic Press: San Diego 1998 477–509
Marmont AM . New horizons in the treatment of autoimmune diseases: immunoablation and stem cell transplantation Ann Rev Med 2000 51: 115–134
Tyndall A, Fassas A, Passweg J et al. Hematopoietic stem cell transplant for autoimmune disease Bone Marrow Transplant 1999 24: 729–734
Euler HH, Marmont AM, Bacigalupo A et al. Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation Blood 1996 88: 3621–3625
W Rosler, B Manger, R Repp et al. Autologous PBPCT in a patient with lymphoma and Sjogren’s syndrome: complete remission of lymphoma withouth control of the autoimmune disease Bone Marrow Transplant 1998 22: 211–214
Lopez-Cubero SO, Sullivan KM, McDonald GB . Course of Crohn’s disease after allogeneic marrow transplantation Gastroenterology 1998 114: 433–440
Greenstein AJ, Gennuso R, Sachar DB et al. Extraintestinal cancers in inflammatory bowel disease Cancer 1985 56: 2914–2921
Kumar S, Fend F, Quintanilla-Martinez L et al. Epstein–Barr virus-positive primary gastrointestinal Hodgkin’s disease: association with inflammatory bowels disease and immunosuppression Am J Surg Pathol 2000 24: 66–73
Toyoda H, Wang SJ, Yang H et al. Distinct associations of HLA class II genes with inflammatory bowels disease Gastroenterology 1993 104: 741–748
Prochazka EJ, Terasaki PI, Park MS et al. Association of primary sclerosing cholangitis with HLA-DRw52a New Engl J Med 1990 322: 1842–1844
Gianni AM, Bregni M, Siena S et al. 5-year update of the Milan Cancer Institute randomized trial of high-dose sequential (HDS) vs MACOP-B therapy for diffuse large-cell lymphomas Proc Am Soc Clin Oncol 1994 13: 373
Marmont A . Stem cell transplantation for severe autoimmune disorders: progress and problems Haematologica 1998 83: 733–743
Cavenagh JD, Milne TM, Macey MG et al. Thymic function in adults: evidence derived from immune recovery patterns following myeloablative chemotherapy and stem cell infusion Br J Haematol 1997 97: 673–676
Musso M, Porretto F, Crescimanno A et al. Autologous peripheral blood stem and progenitor (CD34+) cell transplantation for systemic lupus erythematosus complicated by Evans syndrome Lupus 1998 7: 1–3
Musso M, Porretto F, Crescimanno A et al. Successful treatment of resistant thrombotic thrombocytopenic purpura/hemolytic uremic syndrome with autologous peripheral blood stem and progenitor (CD34+) cell transplantation Bone Marrow Transplant 1999 24: 207–210
Hawkey CJ, Snowden JA, Lobo A et al. Stem cell transplantation for inflammatory bowel disease: practical and ethical issues Gut 2000 46: 869–872
Acknowledgements
We thank Prof Alberto M Marmont for fruitful and stimulating discussions.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Musso, M., Porretto, F., Crescimanno, A. et al. Crohn’s disease complicated by relapsed extranodal Hodgkin’s lymphoma: prolonged complete remission after unmanipulated PBPC autotransplant. Bone Marrow Transplant 26, 921–923 (2000). https://doi.org/10.1038/sj.bmt.1702621
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702621
Keywords
This article is cited by
-
Stem cell therapy for inflammatory bowel disease
Journal of Gastroenterology (2015)
-
The Risk of Cancer in Patients with Crohn's Disease
Diseases of the Colon & Rectum (2007)
-
Complete remission of Crohn's disease after high-dose cyclophosphamide and autologous stem cell transplantation
Bone Marrow Transplantation (2003)
-
Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases
Bone Marrow Transplantation (2002)
-
Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: Getting closer to a cure?
International Journal of Hematology (2002)